Arcturus Therapeutics Ltd. General and Administrative Expense
Arcturus Therapeutics Ltd. reported General and Administrative Expense of $3.53 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2019-05-13
- Arcturus Therapeutics Ltd. general and administrative expense for the quarter ending 2019-03-31 was $3.53M, a 30.68% decline year-over-year.
- Arcturus Therapeutics Ltd. general and administrative expense for the quarter ending 2018-12-31 was $3.44M, a 30.64% increase year-over-year.
- Arcturus Therapeutics Ltd. general and administrative expense for the quarter ending 2018-09-30 was $3.81M, a 33.87% increase year-over-year.
- Arcturus Therapeutics Ltd. general and administrative expense for the quarter ending 2018-06-30 was $8.23M, a 678.17% increase year-over-year.
- Arcturus Therapeutics Ltd. general and administrative expense for fiscal 2018 was $20.58M, a 171.82% increase from fiscal 2017.
- Arcturus Therapeutics Ltd. general and administrative expense for fiscal 2017 was $7.57M.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month | General and Administrative Expense 12 month as first filed | General and Administrative Expense 71 month |
|---|---|---|---|---|---|---|---|
| 2019-03-31 | $3.53M 10-Q · filed 2019-05-13 | $6.97M derived: sum of 2 quarters · filed 2019-05-13 | $10.79M derived: sum of 3 quarters · filed 2019-05-13 | $19.02M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-12-31 | $3.44M derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $7.25M derived: sum of 2 quarters · filed 2019-03-18 | $15.48M derived: sum of 3 quarters · filed 2019-03-18 | $20.58M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $3.81M 6-K · filed 2018-11-07 | $12.04M derived: sum of 2 quarters · filed 2018-11-07 | $17.14M 6-K · filed 2018-11-07 | $19.77M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-06-30 | $8.23M 6-K · filed 2018-11-07 | $13.33M 6-K · filed 2018-09-28 | $15.96M derived: sum of 3 quarters · filed 2019-05-13 | $18.81M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2018-03-31 | $5.10M 10-Q · filed 2019-05-13 | $7.73M derived: sum of 2 quarters · filed 2019-05-13 | $10.58M derived: sum of 3 quarters · filed 2019-05-13 | $11.64M derived: sum of 4 quarters · filed 2019-05-13 | |||
| 2017-12-31 | $2.63M 6-K · filed 2018-11-07 | $3.96M 6-K · filed 2018-09-28 | $5.48M derived: sum of 2 quarters · filed 2018-11-07 | $6.54M derived: sum of 3 quarters · filed 2018-11-07 | $7.57M 10-K · filed 2019-03-18 | ||
| 2017-09-30 | $2.85M 6-K · filed 2018-11-07 | $1.52M 6-K · filed 2018-09-28 | $3.90M derived: sum of 2 quarters · filed 2018-11-07 | $4.94M 6-K · filed 2018-11-07 | |||
| 2017-06-30 | $1.06M 6-K · filed 2018-11-07 | $2.09M 6-K · filed 2018-09-28 | |||||
| 2017-03-31 | $1.03M 6-K · filed 2018-11-07 | ||||||
| 2016-12-31 | $3.45M 20-F · filed 2018-05-14 | $5.36M 20-F · filed 2017-04-28 | |||||
| 2015-12-31 | $2.57M 20-F · filed 2018-05-14 | $4.99M 20-F · filed 2016-03-04 | |||||
| 2014-12-31 | $5.84M 20-F · filed 2017-04-28 | ||||||
| 2013-12-31 | $3.22M 20-F · filed 2016-03-04 | $7.27M 20-F · filed 2014-03-28 | |||||
| 2012-12-31 | $683.00K 20-F · filed 2015-02-27 | ||||||
| 2011-12-31 | $2.08M 20-F · filed 2014-03-28 |